Picture of Smith & Nephew logo

SNN Smith & Nephew News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

REG - Smith & Nephew Plc - Director/PDMR Shareholding




 



RNS Number : 7324Y
Smith & Nephew Plc
14 May 2021
 

SMITH & NEPHEW PLC

 

14 May 2021

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2020 final dividend payment on 12 May 2021.

Date of Transaction

2021 - 05 - 12

Place of Transaction

London Stock Exchange (XLON)

 

Name (Position)

Director / PDMR

Price

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Bradley Cannon

(President Sports Medicine & ENT)

PDMR

£15.269779

129.64031

N/A Single Transaction

77,295.40344 (including 2,101.64550 in ADS')

0.00873%

Phil Cowdy

(Chief Business Development & Corporate Affairs Officer)

PDMR

£15.269779

112.08811

N/A Single Transaction

45,410.28786

0.00513%

Myra Eskes

(President APAC Region)

PDMR

£15.269779

197.38513

N/A Single Transaction

18,332.32816

0.00207%

Simon Fraser

(President Advanced Wound Management)

PDMR

£15.269779

92.76422

N/A Single Transaction

8,615.56333

0.00097%

Mark Gladwell

(President Operations & GBS)

PDMR

£15.269779

96.46099

N/A Single Transaction

96.90438

0.00001%

Melissa Guerdan

(Chief Quality & Regulatory Affairs Officer)

PDMR

£15.269779

99.85666

N/A Single Transaction

9,274.28002

0.00105%

Skip Kiil

(President Orthopaedics)

PDMR

£15.269779

99.50036

N/A Single Transaction

12,128.03780

0.00137%

Catheryn O'Rourke

(Chief Legal & Compliance Officer)

PDMR

£15.269779

583.31782

N/A Single Transaction

82,100.55347 (including 5,818.25734 in ADS')

0.00928%

Susan Swabey

(Company Secretary)

PDMR

£15.269779

190.40720

N/A Single Transaction

49,416.24672

0.00558%

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

 

Vickie Reuben  

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477410

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFESESISLIL

Recent news on Smith & Nephew

See all news